If you are found to be eligible to take part in this study, you will be assigned to 1 of 6 study cohorts, based on when you join this study and on what treatments you have already received. Participants who have already received treatments called hypomethylating agents will be in Cohorts 1-3. Participants who have not received treatment will be in Cohorts 4-6: